RE:While we wait... From a stock price standpoint alone, to your point it does seem like something good shoudl happen eventually even if it's not a moonshot. As long as the clinical trial data doesn't take a turn for the worse for whatever reason, or as long as they haven't designed the trial incorrectly, etc, but it seems like they've been through most of those speedbumps and corrected as needed.